NCT00003144View on ClinicalTrials.gov

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

April 30, 2001

Conditions
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

amifostine trihydrate

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00003144 - Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter